Rapport Therapeutics, Inc. Common Stock (RAPP) — Analyst estimates
Consensus analyst estimates for Rapport Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 20.00M | -1.06 | 2 |
| 2027 | 20.00M | -1.21 | 2 |
| 2028 | 0 | -4.95 | 8 |
| 2029 | 30.11M | -4.93 | 6 |
| 2030 | 70.83M | -3.97 | 6 |
Consensus analyst estimates by fiscal year.